BAKU, Azerbaijan, November 11
By Tamilla Mammadova – Trend:
One of the largest in the Georgian pharmaceutical market, Aversi Pharma Ltd., has published consolidated financial statements for 2019, according to which the company's operating profit went down by 77 percent, Trend reports.
According to the data of 2019, the operating profit of Aversi Pharma Ltd amounted to 3.17 million lari ($954,608) against 13.74 million lari ($4.1 million) in 2018.
It’s worth mentioning that in 2019 the company's assets increased to 333.74 million lari ($100.5 million), while in 2018 they made 292.13 million lari ($87.9 million).
According to reports, the company’s financial ratios in 2019 deteriorated compared to 2018 mainly due to the lari’s devaluation against the dollar and the euro.
Aversi-Pharma Ltd. is a limited liability company, which was founded on May 14, 1999. The company’s main activity is retail and wholesale trade of pharmaceutical and toiletries.
---
Follow the author on Twitter: @Mila61979356